NNE · Nano Nuclear Energy Inc

Nano Nuclear Energy Inc (NNE) reported a Q2 FY2026 net loss of -$9.2 million, a 56.9% improvement from -$21.3 million in the prior year quarter. This narrowing reflects normalization in equity-based compensation, which had inflated prior-period losses, even as core operating costs rose to support expanding research and development activities. Diluted EPS followed suit, improving 68.4% to -$0.18 from -$0.57, underscoring the impact of moderated non-cash expenses relative to the share base.

Cash dynamics highlighted the company's investment phase. Net cash used in operating activities widened to -$5.6 million from -$3.4 million year-over-year, primarily due to the larger net loss and shifts in working capital accounts. This increase stems from elevated professional fees and additional office and staff costs required to sustain R&D momentum, as noted in management's discussion. Capital expenditures surged to $8.8 million from $3.6 million, directed toward initial facility capabilities emphasizing research, development, and prototype support. The resulting free cash flow of -$14.4 million underscores heavy spending to advance microreactor technologies like KRONOS MMR, with manufacturing scale-up planned post-regulatory approvals and commercial demand.

Operational progress aligns with these investments. Facilities like the Oak Brook acquisition position the company for prototype work, while broader efforts address fuel qualification, licensing, and regulatory compliance. Management emphasizes that significant capital remains essential for facility construction, prototype builds, and workforce expansion. Global supply-chain conditions, vendor qualifications, and domestic manufacturing availability continue to influence development costs and timelines, with expectations for subsequent reactors' capital costs to decline through supply chain scaling, factory fabrication, and modular assembly.

Looking ahead, management expects operating losses and negative cash flows to potentially exceed 2025 and 2026 levels, driven by intensifying R&D expenses. Achieving the long-term strategy—commercializing microreactors for AI data centers and off-grid applications—will necessitate additional capital raises or alternative financing. These trends, including factors impacting the KRONOS program, are anticipated to shape ongoing results, balancing de-risking milestones against funding demands in a capital-intensive sector.